CACNA2D4 Membrane Protein Introduction

Introduction of CACNA2D4

CACNA2D4, voltage-dependent calcium channel subunit alpha-2/delta-4, is encoded by CACNA2D4 gene. It belongs to the alpha-2/delta subunit family which has been extensively studied during the past few decades because it offers various functions in calcium channel regulations and the possibilities for diseases treatment. CACNA2D4 is commonly expressed in many kinds of endocrine cells, such as the paneth cells of the small intestine, the erythroblasts in the fetal liver as well as the zona reticularis of the adrenal gland. Meanwhile, it can also regulate calcium current density and activation/inactivation kinetics of the calcium channel.

Basic Information of CACNA2D4
Protein Name Voltage-dependent calcium channel subunit alpha-2/delta-4
Gene Name CACNA2D4
Aliases RCD4
Organism Homo sapiens (Human)
UniProt ID Q7Z3S7
Transmembrane Times 1
Length (aa) 1137

Function of CACNA2D4 Membrane Protein

CACNA2D4 is a protein of the voltage-dependent calcium channel complex. It is known to regulate high voltage activated calcium channels mainly by increasing channel presence on the cell membrane, and by modulating channel gating properties. Researches conducted on CACNA2D4 indicate that it is related to many diseases, for instance, retinal cone dystrophy 4 and retinitis pigmentosa. In this condition, it has been regarded as a potential therapeutic target in the retina. The mutations of CACNA2D4 have been reported to cause cone and cone-rod dystrophies in a human family and in a spontaneous mouse model.

Structure of voltage-gated calcium channels. Fig.1 Structure of voltage-gated calcium channels.

Application of CACNA2D4 Membrane Protein in Literature

  1. Gustafson K., et al. Whole Genome Sequencing Revealed Mutations in Two Independent Genes as the Underlying Cause of Retinal Degeneration in an Ashkenazi Jewish Pedigree. Genes (Basel). 2017, 8(9). PubMed ID: 28837078

    This article conducts whole exome sequencing (WES) and whole genome sequencing (WGS) to analyze genetic variants in two unaffected family members. The results show that one heterozygous deletion in CACNA2D4, and the other homozygous deletion in a retina transcript of C21orf2 are related with retinal degeneration.

  2. Cecil C.A., et al. Epigenetic signatures of childhood abuse and neglect: Implications for psychiatric vulnerability. J Psychiatr Res. 2016, 83: 184-194. PubMed ID: 27643477

    This article reveals that novel potential biomarkers (GABBR1, GRIN2D, CACNA2D4, PSEN2) support a molecular link between maltreatment and poor health outcomes in epigenetic signatures of childhood abuse and neglect.

  3. Bacchi N., et al. A New Splicing Isoform of Cacna2d4 Mimicking the Effects of c.2451insC Mutation in the Retina: Novel Molecular and Electrophysiological Insights. Invest Ophthalmol Vis Sci. 2015, 56(8): 4846-56. PubMed ID: 26218913

    Authors in this group examine the presence and absence of the mutation of CACNA2D4 in vivo on mouse retina and in vitro in HEK293T cells by RT-PCR. The data show the c.2451insC mutation has an effect on splicing and increases the proportion of transcripts including E25b.

  4. Prabhu S., et al. Ultrafast genome-wide scan for SNP-SNP interactions in common complex disease. Genome Res. 2012, 22(11): 2230-40. PubMed ID: 22767386

    This article focuses on a novel algorithmic approach to find the association between SNPs and diseases. The data indicate that RYR2 on chr1q43 and CACNA2D4 on chr12p13 are significantly related with the Wellcome Trust bipolar disorder.

  5. Van Den Bossche M.J., et al. Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage-dependent calcium channels in psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet. 2012, 159B(4): 465-75. PubMed ID: 22488967

    Authors carry on a genome-wide association study to identify the association between CACNA1C and bipolar disorder (BPD). Meanwhile, they analyze the SNP variants of CACNA2D4 in two unrelated late onset bipolar I patients and in one control individual. These results demonstrate that a CACNA2D4 deletion and a CACNA1C mutation in BPD patients could be biomarkers for the clinic.

CACNA2D4 Preparation Options

To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-CACNA2D4 antibody development services.

As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.

All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.

Online Inquiry

Verification code
Click image to refresh the verification code.


USA: 45-1 Ramsey Road, Shirley, NY 11967, USA
UK: 167-169 Great Portland Street, 5th Floor, London, W1W 5PE
Germany: Heidenkampsweg 58, 20097 Hamburg, Germany
Call us at:
USA: 1-631-381-2994
Germany: 44-207-097-1828
Fax: 1-631-207-8356
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us